10-Q: Turning Point Brands Sees Strong Q2 Growth, Boosted by Stokers

Turning Point Brands reports significant revenue and profit increases in Q2 2025, driven by robust performance in its Stokers segment, despite a decline in Zig-Zag products and ongoing internal control remediation.

Summary

• Consolidated net sales increased by 25.1% to $116.6 million for the three months ended June 30, 2025, compared to $93.2 million in the prior year.
• Net income attributable to Turning Point Brands, Inc. rose by 11.0% to $14.5 million for the three months ended June 30, 2025, up from $13.0 million.
• Diluted earnings per share (EPS) increased to $0.79 for the three months ended June 30, 2025, from $0.68 in the same period last year.
• The Stokers products segment saw net sales surge by 62.9% to $69.6 million, primarily driven by a $26.1 million growth in modern oral products and $1.1 million in Stokers MST.
• The Zig-Zag products segment experienced a 6.9% decrease in net sales to $47.0 million, mainly due to declines in cigar products, U.S. papers and wraps, and Canadian products, partially offset by a $4.3 million increase in Clipper lighter sales.
• Gross profit increased by 32.2% to $66.6 million, with the gross profit margin improving to 57.1% from 54.1% year-over-year.
• Selling, general, and administrative expenses increased by 38.0% to $40.3 million, primarily due to higher shipping and selling costs related to modern oral sales, PMTA expenses, and joint venture related expenses.
• Operating income increased by 15.1% to $26.3 million, though operating income as a percentage of net sales decreased to 22.6% from 24.5%.
• Interest expense, net, increased by 69.0% to $5.1 million due to the issuance of 7.625% Senior Secured Notes due 2032 (2032 Notes) to redeem the lower-rate 2026 Notes.
• A $0.9 million impairment charge was recorded on the investment in Old Pal, reducing its fair value to $5.6 million.
• Cash on hand significantly increased to $109.9 million as of June 30, 2025, from $46.2 million at December 31, 2024.
• The company has $66.5 million of available liquidity under its $75.0 million asset-backed revolving credit facility (2023 ABL Facility), with no outstanding borrowings.
• The share repurchase authorization was increased by $77.9 million to an aggregate of $100.0 million on November 6, 2024, with $100.0 million remaining available.
• The company successfully implemented a new ERP system in April 2025, aimed at enhancing internal controls.
• A material weakness in internal controls over financial reporting related to IT general controls (ITGCs) was identified and is expected to be remediated by the end of fiscal year 2025.

Sentiment

Score: 7

Explanation: The company demonstrated strong financial performance with significant revenue and profit growth, primarily driven by its Stokers segment, particularly modern oral products. Liquidity improved substantially, and debt was refinanced to a longer maturity. While the Zig-Zag segment declined and a material weakness in internal controls persists, the overall positive financial trajectory and proactive management actions warrant a favorable sentiment, though tempered by segment-specific challenges and control issues.

Positives

• Net sales increased by 25.1% for the three months ended June 30, 2025, demonstrating strong top-line growth.
• The Stokers products segment showed exceptional growth of 62.9% in net sales, driven by modern oral products and MST, indicating successful product diversification and market penetration.
• Gross profit increased by 32.2%, and the gross profit margin improved to 57.1%, reflecting better product mix and operational efficiency.
• Net income attributable to Turning Point Brands, Inc. increased by 11.0%, and diluted EPS improved to $0.79, indicating enhanced profitability.
• Cash on hand significantly increased to $109.9 million, providing strong liquidity.
• The company successfully refinanced its 2026 Notes with new 2032 Notes, extending debt maturity and improving the capital structure.
• A substantial share repurchase authorization of $100.0 million remains, signaling potential for future shareholder returns.
• The successful implementation of a new ERP system in April 2025 is a positive step towards strengthening internal controls and operational efficiency.

Negatives

• The Zig-Zag products segment experienced a 6.9% decline in net sales, primarily due to decreases in cigar products, U.S. papers and wraps, and Canadian products.
• Selling, general, and administrative expenses increased significantly by 38.0%, outpacing revenue growth, partly due to increased shipping and selling costs for modern oral products and joint venture related expenses.
• Operating income as a percentage of net sales decreased to 22.6% from 24.5%, indicating some margin compression at the operating level.
• Interest expense, net, increased by 69.0% due to the higher interest rate and principal amount of the newly issued 2032 Notes.
• An impairment charge of $0.9 million was recorded on the Old Pal investment, reflecting a decrease in its fair value.
• The company recognized a $1.2 million loss on extinguishment of debt related to the redemption of the 2026 Notes.

Risks

• Declining sales of traditional tobacco products and the overall tobacco industry.
• Dependence on a small number of third-party suppliers and producers, posing supply chain disruption risks.
• Potential termination, challenge, or restriction of licenses to use certain brands or trademarks.
• Failure to maintain consumer brand recognition and loyalty, and inability to adapt to changing consumer preferences.
• Reliance on relationships with several large retailers and national chains for product distribution.
• Intense competition, including from illicit sources, which can damage brand equity.
• Contamination of tobacco supply or products.
• Uncertainty and continued evolution of product markets.
• Complications with the design or implementation of the new enterprise resource planning (ERP) system could adversely impact business and operations.
• Product recalls.
• Substantial and increasing regulation, including potential changes in U.S. Food and Drug Administration (FDA) enforcement priorities and marketing denials.
• Products containing nicotine are considered highly addictive.
• Requirement to maintain compliance with Master Settlement Agreement (MSA) escrow accounts.
• Possible significant increases in federal, state, and local tobaccoand nicotine-related taxes.
• Products are subject to developing and unpredictable regulation, such as court actions impacting obligations.
• Sensitivity of end-customers to increased sales taxes and adverse economic conditions, including inflation and declines in purchasing power.
• Possible increasing international control and regulation.
• Failure to comply with environmental, health, and safety regulations.
• Imposition of significant tariffs on imports into the U.S.
• Lack of scientific information regarding the long-term health effects of certain substances in products.
• Significant product liability litigation.
• High amount of indebtedness and potential impact on credit rating and access to capital markets.
• Terms of indebtedness may restrict current and future operations.
• Inability to establish and maintain effective internal controls over financial reporting, specifically a material weakness in IT general controls (ITGCs).
• Corporate governance provisions (certificate of incorporation, bylaws, Delaware law) could discourage acquisition bids or merger proposals.
• Ownership limits by 'Restricted Investors' may affect common stock liquidity and rights.
• Future sales of common stock could reduce stock price, and additional capital raises may dilute ownership.
• Issuance of preferred stock could adversely affect common stock voting power or value.
• Business may be damaged by events outside of control, such as epidemics, political upheavals, or natural disasters.
• Adverse impact of climate change and related legal/regulatory requirements.
• Reliance on information technology and risks of cybersecurity/privacy breaches, including due to artificial intelligence.
• Failure to manage growth effectively.
• Failure to successfully identify, negotiate, complete, or integrate suitable acquisition opportunities.
• Fluctuations in financial results.
• Exchange rate fluctuations.
• Adverse U.S. and global economic conditions.
• Departure of key management personnel or inability to attract and retain talent.
• Infringement on or misappropriation of intellectual property.
• Third-party claims of intellectual property infringement.
• Impairment of intangible assets, including trademarks and goodwill.

Future Outlook

The company expects to have ample liquidity for foreseeable operating cash requirements due to its strong cash balance, free cash flow generation, and borrowing availability. It aims to grow through investing in organic growth, acquisitions, and joint ventures across all product categories. The remediation of the material weakness in internal controls is expected to be completed by the end of fiscal year 2025. The company is currently evaluating the potential impact of the recently signed One Big Beautiful Bill Act (OBBBA) on its financial position and results of operations, but cannot reasonably estimate the financial effect at this time.

Management Comments

• Management views business performance through segments that closely resemble the performance of major product lines.
• The company believes there are meaningful opportunities to grow through investing in organic growth, acquisitions and joint ventures across all product categories.
• The company does not expect meaningful additional revenue from Clipper in future periods.
• The company believes the inventory loss from the December 2023 tornado damage is probable of being fully recovered under its stock throughput insurance policy.
• The company intends to continue to consistently use the same group of publicly traded peer companies to determine expected volatility until sufficient information regarding volatility of its share price becomes available or until the selected companies are no longer suitable for this purpose.
• The company will continue to use the simplified method presented by SEC Staff Accounting Bulletin No. 107 to calculate expected holding periods for stock options until sufficient historical exercise experience is available.
• The company expects to complete the remediation of the material weakness in internal controls by the end of fiscal year 2025, as at that time the referenced controls will have been in place for a sufficient period of time to demonstrate operating effectiveness.

Industry Context

The company operates in the alternative smoking accessories and Other Tobacco Products (OTP) industries. The alternative smoking accessories market is experiencing robust secular growth driven by cannabinoid legalization in the U.S. and Canada, and evolving consumer perception. The OTP industry, however, exhibited low-single-digit consumer unit annualized declines in 2024. The company's strong growth in modern oral products within its Stokers segment aligns with evolving consumer preferences towards next-generation products, contrasting with the decline in its more traditional Zig-Zag segment. The industry faces increasing regulatory scrutiny, particularly from the FDA, and potential flavor bans, which could significantly impact product lines.

Comparison to Industry Standards

• The company's strong growth in modern oral products (Stokers segment) suggests effective adaptation to evolving consumer preferences, similar to how companies like Altria (with On!) or British American Tobacco (with Velo) are expanding their nicotine pouch offerings to capture market share in the smokeless and reduced-risk product categories.
• The decline in the Zig-Zag segment's traditional products (cigars, papers/wraps) reflects broader industry trends where conventional tobacco product sales are facing secular declines due to health concerns, changing consumer habits, and increased regulation, comparable to challenges faced by legacy tobacco companies in their traditional cigarette or cigar portfolios.
• The improved gross profit margin for the Stokers segment, driven by modern oral products, indicates a favorable product mix shift towards higher-margin offerings, a strategic goal for many diversified tobacco companies seeking to offset declines in traditional segments.
• The company's investment in a captive insurance company (Interchange, IC) to write a portion of its insurance coverage is a sophisticated risk management strategy, often employed by larger corporations to manage specific liabilities like product liability, similar to how major pharmaceutical or manufacturing firms might use captives.
• The ongoing material weakness in IT general controls, while being remediated, highlights a common challenge for companies undergoing significant system implementations (like the new ERP system), where ensuring robust IT governance and controls is critical for financial reporting integrity, a challenge that has affected various companies across industries during similar transitions.

Corporate Governance

Legal Proceedings

• The company is subject to significant product liability litigation, similar to other major tobacco companies, with potential for substantial punitive and compensatory damages, which are not currently reasonably estimable or accrued.
• Legal expenses of $0.5 million were incurred in connection with litigation related to an insurance claim for the three and six months ended June 30, 2025.

Related Party Transactions

• On January 2, 2025, the company contributed 100% of its interest in South Beach Brands LLC (SBB) to General Wireless Operations, Inc. (GWO), a joint venture between the company and Standard General, LP, in exchange for 49% of GWO common stock.
• The company has the right to redeem the contribution of SBB from GWO at fair market value under certain circumstances.
• The company received a purchase option with a 15-year term to acquire the remaining 51% equity interest in GWO, with an initial exercise price of $22.0 million, decreasing over time based on tax sharing payments to Standard General, LP.
• On August 8, 2025, SBB acquired a Canadian distribution business, and 10233625 Canada Corp. (Turning Point Brands Canada), in which the company has a 65% controlling financial interest, purchased an option from GWO to acquire this business for approximately $20.0 million.
• SBB will pay management fees to Turning Point Brands Canada for services, approximately up to $7.0 million per annum.

Stakeholder Impact

• Shareholders: Positive impact from increased net income, diluted EPS, and a substantial share repurchase authorization. The dividend policy continues, subject to debt covenants. Potential dilution from future equity sales is a risk.
• Employees: The implementation of a new ERP system may impact workflows and require training, but is intended to improve operational efficiency. Stock compensation plans continue to incentivize employees.
• Customers: Continued product availability through diversified distribution channels. The growth in modern oral products indicates responsiveness to evolving consumer preferences.
• Suppliers: Dependence on a small number of third-party suppliers poses a risk to supply chain stability.
• Creditors: The refinancing of the 2026 Notes with the 2032 Notes extends debt maturity, providing more stability, but at a higher interest rate. Debt covenants restrict certain corporate actions, including dividends, if not met.
• Regulatory Authorities: Ongoing engagement with the FDA regarding PMTA applications and compliance with evolving regulations, including potential flavor bans, which could impact product offerings and market access.

Next Steps

• Continue to invest in organic growth, acquisitions, and joint ventures across all product categories.
• Complete the remediation of the material weakness in internal controls over financial reporting by the end of fiscal year 2025.
• Monitor the impact of the One Big Beautiful Bill Act (OBBBA) on financial position and results of operations.
• Evaluate the accounting treatment for the acquisition of a Canadian distribution business by South Beach Brands LLC (SBB) and the option purchased by Turning Point Brands Canada.
• Begin quarterly payments for the option price to acquire the Canadian distribution business starting February 2026.
• Pay semi-annual interest on the 2032 Notes, commencing September 15, 2025.
• Opportunistically execute the $100.0 million share repurchase program based on market dynamics.

Key Dates

Recommendation

The company's strong Q2 2025 performance, marked by a 25.1% increase in net sales and an 11.0% rise in net income, is compelling. This growth is primarily fueled by the Stokers segment, particularly its modern oral products, demonstrating successful adaptation to evolving consumer preferences and a strong position in a growing market niche. The improved gross profit margin and significant increase in cash on hand bolster the company's financial health and liquidity. While the decline in the Zig-Zag segment and the identified material weakness in internal controls are areas to monitor, the company is actively addressing the latter with a new ERP system implementation. The substantial remaining share repurchase authorization also signals a commitment to shareholder returns. Given the robust growth in a key segment and overall improved financial metrics, the stock presents a favorable buying opportunity for investors seeking exposure to the evolving tobacco and nicotine product landscape.

Keywords

Tobacco, Nicotine, Vaping, Smokeless Tobacco, Modern Oral Products, Rolling Papers, Cigars, Stokers, Zig-Zag, SEC Filing, Quarterly Report, Financial Results, Consumer Products, Specialty Marketing, Distribution, ERP System, Internal Controls, Debt Refinancing, Share Repurchase